Mikiko Ise1, Chikara Sakai, Kyoya Kumagai. Show Affiliations » 1. Department of Hematology-Oncology, Chiba Cancer Center, 666-2 Nitona-cho, Chuo-ku, Chiba, Chiba, 260-8717, Japan, mise@chiba-cc.jp.
Abstract
Entities: Disease
Mesh: See more » AgedAntineoplastic Combined Chemotherapy Protocols/adverse effectsBoronic Acids/administration & dosageBoronic Acids/adverse effectsBortezomibCerebrospinal Fluid/cytologyDexamethasone/administration & dosageDexamethasone/adverse effectsFatal OutcomeFemaleHumansMagnetic Resonance ImagingMeningeal Neoplasms/cerebrospinal fluidMeningeal Neoplasms/chemically inducedMeningeal Neoplasms/diagnosisMeningeal Neoplasms/pathologyMultiple Myeloma/cerebrospinal fluidMultiple Myeloma/chemically inducedMultiple Myeloma/diagnosisMultiple Myeloma/pathologyPlasma Cells/pathologyPyrazines/administration & dosagePyrazines/adverse effectsThalidomide/administration & dosageThalidomide/adverse effects
Substances: See more » Boronic AcidsPyrazinesThalidomideBortezomibDexamethasone
Year: 2013 PMID: 23955113 DOI: 10.1007/s12185-013-1415-8
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490